News | September 29, 2008

The Modern DeBakey VAD Introduced for the First Time in the U.S.

September 30, 2008 - The HeartAssist 5 Pediatric VAD will be introduced for the first time in the U.S. Oct. 2-4 at the 16th annual meeting of the International Society for Rotary Blood Pumps (ISRBP) in Houston.

The Modern DeBakey VAD is the only pediatric ventricular assist device (VAD) that benefited from years of hands-on leadership and support by Dr. Michael DeBakey. It is the only FDA-approved pediatric VAD in the world. Originally created through a collaboration between Dr. DeBakey, colleague Dr. George Noon, NASA and the Baylor College of Medicine, it is one of the smallest VADs in the world. It can support the failing left ventricle of the heart with blood flow of 1-10 L/min.

The U.S. introduction of the HeartAssist 5 Pediatric VAD, The Modern DeBakey VAD, occurs less than three months after the internationally renowned surgeon’s death from natural causes. Dr. DeBakey passed away at age 99 on July 11. He would have celebrated his 100th birthday on Sept. 7, 2008.

The HeartAssist 5 Pediatric VAD is the only VAD with the exclusive direct flow measurement system, which provides measurement of blood flow through the VAD. Since pediatric VADs are designed to support failing hearts in children, precise blood flow measurement can prove vital for patients in critical condition. At best, other devices only approximate blood flow, which can be unreliable, or provide no blood flow data at all.

The HeartAssist 5 Pediatric VAD pump weighs 92 grams and measures 2.8 x 1.2 inches. Because of its small size, it is one of the few pediatric VADs that can be implanted above the diaphragm in the pericardial space surrounding the heart, which reduces the risk of complications.

Dr. DeBakey will be honored multiple times during this week. On the evening of Oct. 1, Dr. Noon and heart assist device leaders will celebrate the re-grand opening of the International Center for Medical Technologies museum and hold an ISRBP presidential reception in honor of Dr. DeBakey

The following afternoon at the opening session of ISRBP, Dr. Noon and associates will pay tribute to Dr. DeBakey and his lifelong accomplishments in heart surgery and the DeBakey VAD. There will also be a Tribute to Dr. Michael E. DeBakey and Awards Gala on Oct. 3.

In the U.S., the HeartAssist 5, formerly DeBakey VAD Child, is the only FDA-approved pediatric VAD and a bridge-to-transplant IDE clinical study is underway for adult use. In Europe, the HeartAssist 5 is CE Mark approved for both adult and pediatric use. The HeartAssist 5 Straight VAD is CE Mark approved for patients with previous surgeries or complicated anatomies. It is designed to be implanted through the less invasive left thoracotomy.

For more information: www.micromedcv.com

Related Content

Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery | February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
Overlay Init